Last reviewed: June 28, 2026

Last updated: June 28, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Ozempic (semaglutide) was FDA-approved in 2017 specifically for reducing blood sugar in adults with type 2 diabetes, with clinical trials showing an average A1C reduction of 1.5 percentage points. In recent years, the medication has gained widespread attention for its powerful effect on appetite regulation and weight loss, leading many people to ask what Ozempic actually treats and whether it might help them reach their health goals.

The Original Purpose: Ozempic and Type 2 Diabetes Control

Ozempic was developed and approved by the FDA to help adults with type 2 diabetes lower their blood glucose levels when diet and exercise alone are not enough. The medication mimics glucagon-like peptide 1 (GLP-1), a hormone your body naturally produces to signal fullness after eating and to trigger insulin release when blood sugar rises. By activating GLP-1 receptors in the brain and pancreas, semaglutide helps your body use glucose more efficiently and reduces the amount of glucose your liver produces.

Clinical trials demonstrated that Ozempic reduced fasting blood sugar by an average of 30–40 mg/dL and improved long-term glucose control (A1C) in people with type 2 diabetes. Beyond glucose control, many patients also experienced significant weight loss—an unexpected but valuable side effect that prompted further investigation into its use for weight management alone. Today, Ozempic remains a cornerstone medication for diabetes care, but its appetite-suppressing properties have opened a new chapter in how healthcare providers approach weight-related health challenges.

Weight Loss and Metabolic Health: The Secondary Discovery

While Ozempic was not originally designed as a weight loss drug, the mechanism that helps control blood sugar also dramatically reduces appetite. When GLP-1 receptors are activated, signals sent to the brain's appetite center create a lasting sense of fullness, which leads most people to naturally eat less without conscious restriction. This appetite suppression, combined with semaglutide's effect on how your body processes and stores fat, resulted in weight losses of 10–15% of body weight in clinical studies—far exceeding results from traditional dieting or older weight loss medications.

The recognition of semaglutide's weight loss potential led to the development of Wegovy, a higher-dose version specifically approved by the FDA for chronic weight management in adults with obesity or overweight with weight-related health conditions. However, many people now explore compounded semaglutide through precision health providers as an accessible, affordable alternative to manage their weight and improve markers like blood pressure, cholesterol, and inflammation, regardless of whether they have diabetes.

How Semaglutide Works: The GLP-1 Mechanism Explained

Semaglutide is a GLP-1 receptor agonist, meaning it binds to and activates GLP-1 receptors found throughout your body—especially in the pancreas, brain, and gut. This activation triggers a cascade of metabolic changes: your pancreas releases more insulin when blood sugar is high, your liver produces less glucose, your stomach empties more slowly (keeping you fuller longer), and your brain receives stronger hunger-suppressing signals. Unlike older weight loss medications that work through stimulation or other pathways, semaglutide works with your body's natural hormone system rather than against it.

The medication's effects extend beyond appetite control. Research shows that GLP-1 activation also improves how your body responds to insulin (insulin sensitivity), reduces inflammation, and may protect heart and kidney function. This multi-system impact explains why semaglutide has become a cornerstone of modern weight management and metabolic health therapy—it addresses root causes of weight gain and metabolic disease rather than simply reducing calorie intake.

PlexusDx Compounded Semaglutide: Accessible Precision Weight Loss

PlexusDx offers compounded semaglutide injection starting at $149 per month through licensed 503A compounding pharmacies, making personalized GLP-1 therapy accessible without insurance or membership fees. All medications are prepared by licensed pharmacies that meet strict quality and safety standards, and treatment is available to all 50 states. PlexusDx also accepts HSA and FSA funds, reducing your out-of-pocket cost even further if you have a qualified health savings account.

For patients who want to understand their individual genetic predisposition to respond well to semaglutide or other peptide therapies, PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after the first month) that maps 14 metabolic pathways, 49 peptides, and 150+ genetic insights—including variants in GLP1R, GIPR, FTO, and MC4R genes that influence how your body responds to appetite-suppressing therapies. This personalization allows your healthcare provider to optimize your medication choice and dose strategy based on your unique biology.

Safety, Side Effects, and Who Should Consider Semaglutide

Common side effects of semaglutide include nausea, vomiting, diarrhea, and constipation, especially when starting treatment or increasing doses. These effects typically diminish over the first few weeks as your body adjusts to the medication. More serious but rare risks include pancreatitis, gallbladder problems, and changes in kidney function; anyone with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 should not use semaglutide. Always discuss your full medical history with your healthcare provider before starting any GLP-1 therapy.

Semaglutide is most appropriate for adults with type 2 diabetes or those with obesity or overweight who want to improve metabolic health, reduce appetite-driven eating, and lower their risk of heart disease and other weight-related conditions. It is not recommended during pregnancy or if you plan to become pregnant. Your PlexusDx healthcare provider will review your medical history, current medications, and health goals to determine whether semaglutide or an alternative GLP-1 option (like tirzepatide or the Microdose GLP-1 Protocol) is the best fit for you.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is Ozempic approved for weight loss in people without diabetes?

Ozempic itself is FDA-approved only for type 2 diabetes. However, Wegovy—which contains the same active ingredient (semaglutide) at higher doses—is FDA-approved specifically for chronic weight management. Many healthcare providers also prescribe compounded semaglutide off-label for weight management in people without diabetes. PlexusDx offers compounded semaglutide injection starting at $149/month through licensed pharmacies available nationwide.

How much weight can I expect to lose with semaglutide?

Clinical trials show average weight losses of 10–15% of body weight over 16 weeks to one year, though individual results vary widely. Some people lose more, others less, depending on genetics, lifestyle, starting weight, and how long they use the medication. PlexusDx's Precision Peptide Genetic Test can identify your genetic predisposition to respond well to semaglutide and other GLP-1 therapies, helping your provider personalize your treatment plan.

What is the difference between Ozempic, Wegovy, and compounded semaglutide?

Ozempic and Wegovy both contain semaglutide but are FDA-approved for different uses: Ozempic for diabetes, Wegovy for weight loss. Compounded semaglutide is prepared by licensed 503A compounding pharmacies and offers the same active ingredient at a lower cost ($149/month at PlexusDx) without insurance requirements. All three contain identical semaglutide but differ in brand, indication, and price.

Are there people who should not take semaglutide?

Semaglutide is not recommended for people with a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2, severe pancreatitis, or pregnancy. It requires careful monitoring in people with kidney disease, gallbladder problems, or a history of diabetic retinopathy. Always share your complete medical history with your PlexusDx provider before starting treatment.

Can genetic testing help me know if semaglutide will work for me?

Yes. PlexusDx's Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes that influence your body's response to semaglutide and other GLP-1 therapies. The $99 test (available after your first month of treatment) maps 14 pathways and 150+ insights to help your provider optimize your medication choice and dosing strategy based on your unique genetics.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves